Pharma Strategy: Loss of Exclusivity (LOE)   25-slide PPT PowerPoint presentation (PPT)
$29.00

Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Log in to unlock full preview.
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Pharma Strategy: Loss of Exclusivity (LOE) (25-slide PPT PowerPoint presentation (PPT)) Preview Image
Arrow   Click main image to view in full screen.

Pharma Strategy: Loss of Exclusivity (LOE) (PowerPoint PPT)

PowerPoint (PPT) 25 Slides FlevyPro Document

Top 1,000 Best Practice $29.00
FlevyPro price: FREE (included in subscription)
This framework is developed by a team of former McKinsey and Big 4 consultants. The presentation follows the headline-body-bumper slide format used by global consulting firms.
Add to Cart
  


Immediate download
Free lifetime updates

DESCRIPTION

This product (Pharma Strategy: Loss of Exclusivity [LOE]) is a 25-slide PPT PowerPoint presentation (PPT), which you can download immediately upon purchase.

Expiration of a drug patent means end of the branded drug value and revenue stream for a majority of pharmaceutical firms. This loss of exclusivity (LOE) puts to risk a huge amount of money in global pharmaceutical sales.

LOE certainly brings about a steep decline in a drug sales. A brand's unit share declines to about 16% by the time generics arrive and play in the market for a year. However, this is not a "game over" scenario.

This deck discusses 3 key strategies to preserve value for the brands after patent expiration:

1. Preserve Brand Equity and Patient Loyalty
2. Develop an Over-the-Counter (OTC) Version
3. Launch a Generic Version

No matter which LOE strategy a company selects to maintain product revenue, early action and execution is critical.

LOE is part of the different phases of a product's lifecycle and should be strategically thought out and managed. The presentation also highlights other avenues to tap revenue opportunities besides extending a drug's patent life through reformulations and introducing new indications.

The slide deck also includes some slide templates for you to use in your own business presentations.

The PPT provides a comprehensive guide on managing the critical phase of Loss of Exclusivity (LOE) in the pharmaceutical industry. It emphasizes the importance of early planning and execution to mitigate the impact on revenue streams. The strategies outlined are not just theoretical, but are backed by practical templates and checklists to facilitate implementation.

The presentation also delves into the nuances of brand affinity and market dynamics, offering insights into how these factors influence the choice of LOE strategy. It includes a detailed timeline for planning and executing LOE strategies, ensuring that companies can navigate this challenging phase with precision and foresight. This resource is indispensable for pharmaceutical executives aiming to sustain brand value and revenue post-patent expiry.

Got a question about the product? Email us at flevypro@flevy.com. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Best Practices in Pharma Industry PowerPoint Slides: Pharma Strategy: Loss of Exclusivity (LOE) PowerPoint (PPT) Presentation, LearnPPT Consulting


$29.00
FlevyPro price: FREE (included in subscription)
This framework is developed by a team of former McKinsey and Big 4 consultants. The presentation follows the headline-body-bumper slide format used by global consulting firms.
Add to Cart
  

Did you need more documents?

Consider a FlevyPro subscription from $39/month. View plans here.

For $10.00 more, you can download this document plus 2 more FlevyPro documents. That's just $13 each.

ABOUT FLEVYPRO

This document is part of the FlevyPro Library, a curated knowledge base of documents for our FlevyPro subscribers.

FlevyPro is a subscription service for on-demand business frameworks and analysis tools. FlevyPro subscribers receive access to an exclusive library of curated business documents—business framework primers, presentation templates, Lean Six Sigma tools, and more—among other exclusive benefits.

Click here to learn more about FlevyPro and its benefits.

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.




Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab




Read Customer Testimonials

 
"I like your product. I'm frequently designing PowerPoint presentations for my company and your product has given me so many great ideas on the use of charts, layouts, tools, and frameworks. I really think the templates are a valuable asset to the job."

– Roberto Fuentes Martinez, Senior Executive Director at Technology Transformation Advisory
 
"My FlevyPro subscription provides me with the most popular frameworks and decks in demand in today’s market. They not only augment my existing consulting and coaching offerings and delivery, but also keep me abreast of the latest trends, inspire new products and service offerings for my practice, and educate me "

– Bill Branson, Founder at Strategic Business Architects
 
"Last Sunday morning, I was diligently working on an important presentation for a client and found myself in need of additional content and suitable templates for various types of graphics. Flevy.com proved to be a treasure trove for both content and design at a reasonable price, considering the time I "

– M. E., Chief Commercial Officer, International Logistics Service Provider
 
"As a young consulting firm, requests for input from clients vary and it's sometimes impossible to provide expert solutions across a broad spectrum of requirements. That was before I discovered Flevy.com.

Through subscription to this invaluable site of a plethora of topics that are key and crucial to consulting, I "

– Nishi Singh, Strategist and MD at NSP Consultants
 
"Flevy is our 'go to' resource for management material, at an affordable cost. The Flevy library is comprehensive and the content deep, and typically provides a great foundation for us to further develop and tailor our own service offer."

– Chris McCann, Founder at Resilient.World
 
"I am extremely grateful for the proactiveness and eagerness to help and I would gladly recommend the Flevy team if you are looking for data and toolkits to help you work through business solutions."

– Trevor Booth, Partner, Fast Forward Consulting
 
"I have used FlevyPro for several business applications. It is a great complement to working with expensive consultants. The quality and effectiveness of the tools are of the highest standards."

– Moritz Bernhoerster, Global Sourcing Director at Fortune 500
 
"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so "

– Omar HernĂ¡n Montes Parra, CEO at Quantum SFE


Your Recently Viewed Documents

Customers Also Bought These Documents


Customers Also Like These Documents

Related Management Topics


Healthcare Consulting Frameworks Value Chain Analysis Strategic Thinking Strategy Frameworks Consulting Training Financial Analysis Meeting Facilitation/Management Scenario Planning Disruption Chief Strategy Officer Budgeting & Forecasting Strategy Development Cancer Competitive Analysis Pricing Strategy Strategic Analysis Strategic Planning Integrated Financial Model

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S, Balanced Scorecard, Disruptive Innovation, BCG Curve, and many more.